Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease. Article uri icon

Overview

publication date

  • August 16, 2010

Research

keywords

  • Anemia, Aplastic
  • Antibodies, Monoclonal
  • Graft vs Host Disease
  • Immunologic Factors
  • Intestines
  • Receptors, Interleukin-6
  • Stem Cell Transplantation

Identity

Scopus Document Identifier

  • 78049508308

Digital Object Identifier (DOI)

  • 10.1200/JCO.2010.29.1682

PubMed ID

  • 20713858

Additional Document Info

volume

  • 28

issue

  • 30